These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10474022)

  • 1. Hypoglycemic effects of insulin-like growth factor-1 in experimental uremia: can concomitant growth hormone administration prevent this effect?
    Kovacs GT; Worgall S; Schwalbach P; Steichele T; Mehls O; Rosivall L
    Horm Res; 1999; 51(4):193-200. PubMed ID: 10474022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia.
    Kovács GT; Oh J; Kovács J; Tönshoff B; Hunziker EB; Zapf J; Mehls O
    Kidney Int; 1996 May; 49(5):1413-21. PubMed ID: 8731108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of growth hormone or IGF-I to pregnant rats on a reduced diet throughout pregnancy does not prevent fetal intrauterine growth retardation and elevated blood pressure in adult offspring.
    Woodall SM; Breier BH; Johnston BM; Bassett NS; Barnard R; Gluckman PD
    J Endocrinol; 1999 Oct; 163(1):69-77. PubMed ID: 10495409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia.
    Tönshoff B; Powell DR; Zhao D; Durham SK; Coleman ME; Domené HM; Blum WF; Baxter RC; Moore LC; Kaskel FJ
    Endocrinology; 1997 Mar; 138(3):938-46. PubMed ID: 9048593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dosage growth hormone treatment and post-ischemic acute renal failure in the rat.
    Matejka GL; Bengtsson BA
    Growth Horm IGF Res; 1998 Apr; 8(2):151-7. PubMed ID: 10987682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR; Smith-Banks A; Underwood LE
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats.
    Dubuis JM; Deal C; Tsagaroulis P; Clark RG; Van Vliet G
    Endocrinology; 1996 Jul; 137(7):2799-806. PubMed ID: 8770900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia.
    Tönshoff B; Edén S; Weiser E; Carlsson B; Robinson IC; Blum WF; Mehls O
    Kidney Int; 1994 Apr; 45(4):1085-92. PubMed ID: 8007578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of growth and food utilization by human recombinant growth hormone in uremia.
    Mehls O; Ritz E; Hunziker EB; Eggli P; Heinrich U; Zapf J
    Kidney Int; 1988 Jan; 33(1):45-52. PubMed ID: 3352160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
    Kupfer SR; Underwood LE; Baxter RC; Clemmons DR
    J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone administration to mature miniature Brahman cattle treated with or without insulin on circulating concentrations of insulin-like growth factor-I and other metabolic hormones and metabolites.
    Chase CC; Elsasser TH; Spicer LJ; Riley DG; Lucy MC; Hammond AC; Olson TA; Coleman SW
    Domest Anim Endocrinol; 2011 Jul; 41(1):1-13. PubMed ID: 21420268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats.
    Sato M; Frohman LA
    Endocrinology; 1993 Aug; 133(2):793-9. PubMed ID: 8102097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats.
    Thissen JP; Triest S; Underwood LE; Maes M; Ketelslegers JM
    Endocrinology; 1990 Feb; 126(2):908-13. PubMed ID: 2298175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I and growth hormone have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes.
    Sjöberg A; Oscarsson J; Olofsson SO; Edén S
    Endocrinology; 1994 Oct; 135(4):1415-21. PubMed ID: 7925103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between growth hormone/insulin-like growth factor-1 resistance and insulin resistance in non catch-up growth rats born small for gestational age].
    Huang TT; Du ML; Ma HM; Su Z; Gu YF
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2292-6. PubMed ID: 18001556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments.
    Thordarson G; Semaan S; Low C; Ochoa D; Leong H; Rajkumar L; Guzman RC; Nandi S; Talamantes F
    Breast Cancer Res Treat; 2004 Oct; 87(3):277-90. PubMed ID: 15528971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment.
    Edmondson SR; Baker NL; Oh J; Kovacs G; Werther GA; Mehls O
    Kidney Int; 2000 Jul; 58(1):62-70. PubMed ID: 10886550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.